text: Western blot analysis of cells incubated with << imatinib >> demonstrated activation of [[ EGFR ]] and downstream signaling that was reduced by inhibition of mitogen-activated protein/extracellular signal-regulated kinase kinase 1 (MEK1) and EGFR, but not Her2/ErbB2.